Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib

Leukemia

Volumn 26, Issue 4, 2012, Pages 824-826

  Georgiou, G ^a   Efthymiou, A ^a   Vardounioti, I ^a   Boutsikas, G ^a   Angelopoulou, M K ^a   Vassilakopoulos, T P ^a   Kyrtsonis, M C ^a   Plata, E ^a   Tofas, P ^a   Bitsani, A ^a   Bartzi, V ^a   Pessach, I ^a   Dimou, M ^a   Panayiotidis, P ^a  

^a LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CD135 ANTIGEN; CD15 ANTIGEN; CD33 ANTIGEN; CYTARABINE; FLUDARABINE; HLA DR ANTIGEN; IDARUBICIN; IMATINIB; ISOCITRATE DEHYDROGENASE; MICROSOMAL AMINOPEPTIDASE; MITOXANTRONE; MYELOPEROXIDASE; NUCLEOPHOSMIN; STEM CELL FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANEMIA; BONE MARROW BIOPSY; CAPILLARY ELECTROPHORESIS; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTINUOUS INFUSION; CYTOGENETICS; DRUG MEGADOSE; GENE MUTATION; HETEROZYGOSITY; HUMAN; IMMUNOPHENOTYPING; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; MULTIPLE CYCLE TREATMENT; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; PHILADELPHIA CHROMOSOME; PIPERAZINES; PYRIMIDINES;

EID: 84859627566     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.280     Document Type: Letter

References (11)

1. Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 2009; 27: 6041-6605.
2. Groves MJ, Sales M, Baker L, Griffiths M, Pratt N, Tauro S. Factors influencing a second myeloid malignancy in patients with Philadelphia-negative-7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia. Cancer Genet 2011; 204: 39-44.
3. Pawarode A, Sait SN, Nganga A, Coignet LJ, Barcos M, Baer MR. Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities. Leuk Res 2007; 31: 1589-1592. (Pubitemid 47632784)
4. Schafhausen P, Dierlamm J, Bokemever C, Btuemmendorf TH, Bacher U, Zander AR et al. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with imatinib. Cancer Genet Cytogenet 2009; 189: 63-67.
5. Dvorak P, Hruba M, Subrt I. Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia. Leuk Res 2009; 33: 860-861.
6. Paquette RL, Nicoll J, Chalukya M, Gondek L, Jasek M, Sawyers CL et al. Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib. Leuk Res 2010; 34: 708-713.
7. Kronke J, Schlenk RF, Jensen KO, Tschurtz F, Corbacioglu A, Gaidzik VI et al. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group. J Clin Oncol 2011; 29: 2709-2716.
8. Fabarius A, Giehl M, Frank O, Duesberg P, Hochhaus A, Hehlmann R et al. Induction of centrosome and chromosome aberrations by imatinib in vitro. Leukemia 2005; 19: 1573-1578. (Pubitemid 43090401)
9. Bacher U, Hochhaus A, Berger U, Hiddemann W, Hehlmann R, Haferlach T et al. Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha. Leukemia 2005; 19: 460-463. (Pubitemid 40403327)
10. Piccaluga PP, Sabattini E, Bacci F, Agostinelli C, Righi S, Salmi F et al. Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. Leukemia 2009; 23: 1370-1371.
11. Soverini S, Score J, Iacobucci I, Poerio A, Lonetti A, Gnani A et al. IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis. Leukemia 2011; 25: 178-181.